U-M Researchers Home in on Key Player in Pancreatic Cancer Development

The protein Argonaute 2 was found to be critical to the progression from benign lesions into pancreatic cancer, suggesting a therapeutic opportunity.

3:35 PM

Author | Ian Demsky

microscope drawn in blue ink on notepad paper
Image by Stephanie King.

Researchers at the University of Michigan Rogel Cancer Center have identified a protein — Argonaute 2 — that appears to be critical for the progression of benign precursor lesions into pancreatic cancer.

Argonaute 2 interacts with K-RAS, which helps relay signals from the outside of a cell to its nucleus. Mutations in the KRAS gene drive more than 90% of pancreatic cancers, and currently there are no therapies that target these mutations.

Based on their findings, which appear in Nature Communications, the researchers believe developing drugs that target this interaction could present a much needed opportunity to treat pancreatic cancer — the five-year survival rate for which still hovers around 10%.

Working with two genetically engineered mouse models of pancreatic cancer, the diverse team of researchers found mice who lacked Argonaute 2 developed precursor lesions, but the lesions didn't develop further into lethal pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. The study also defined mechanisms that regulate the KRAS-AGO2 interaction.

"Our study supports a two-phase model of pancreatic cancer development. First, the development of the benign lesions which does not require Argonaute 2, and second, the transformation of the lesions into pancreatic cancer, which does require it," says study co-first author Sunita Shankar, Ph.D., a postdoctoral research fellow in the Michigan Center for Translational Pathology. "We are optimistic that targeting this interaction between K-RAS and Argonaute 2 could provide a therapeutic opportunity to stall or prevent the development of pancreatic cancer."

The senior author of the study was Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Endowed Professor of Pathology at Michigan Medicine.

Paper cited: "An Essential Role for Argonaute 2 in EGFR-KRAS Signaling in Pancreatic Cancer Development," Nature Communications. DOI: 10.1038/s41467-020-16309-2


More Articles About:

Lab Notes Pancreatic cancer Cancer Research Cancer: Cancer Types
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Health Lab

New clues to how the tumor microenvironment impacts pancreatic cancer

GOT2 causes metabolic changes that pancreas tumors overcome.
purple and blue microscopic cancer cells with lab note badge on bottom right in yellow and navy
Health Lab

Pumping iron: inhibition of key pathway promotes iron-dependent cell death in pancreatic cancer cells

Cell culture study maps mechanisms underlying a new potential strategy for killing pancreatic cancer cells through a type of cell death known as ferroptosis.
mutlicolored cells merging microscopic blue image with lab note badge in yellow on right
Health Lab

Cholesterol-carrying protein found to help suppress immune response in pancreatic tumor microenvironment

ApoE has known roles in cardiovascular disease and Alzheimer’s, but was not previously implicated in pancreatic cancer.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Computer screens and microscope pictured in a laboratory setting.
Health Lab

Understanding family history key to early detection of pancreatic cancer

How genetic testing and family history help identify individuals at high risk for pancreatic cancer, enabling earlier screening and better treatment outcomes.
Family with mom and dad and three kids sitting on a park bench, dad's arms extended around the family.
Health Lab

Intuition pushed mom to keep checking for breast cancer

Michigan mom had no reason to suspect cancer. But instinct nudged her to find out for sure — and carried her through challenging treatments to remission.